COMP <GO>
GRDN vs COST // FORWARD P/E MULTIPLE
Guardian Pharmacy Services Inc. (Class A) (NYSE) VS. Costco Wholesale Corporation (NASDAQ) • 15-METRIC TALLY: GRDN 7
— COST 6
▲ FORWARD P/E MULTIPLE LEADER: COST
LAST: $40.45 (+0.30%) • MKT CAP: $2.56B
forward-pe
43.8x
LAST: $996.08 (+1.36%) • MKT CAP: $441.39B
forward-pe
39.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDN VS. COST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRDN | COST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.20% | 12.82% | +7.38 | GRDN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.70% | 42.43% | -4.73 | COST | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.3x | 31.4x | +2.94 | COST | /valuation <GO> |
| Free Cash Flow Yield | 3.91% | 2.09% | +1.82 | GRDN | /fcf-yield <GO> |
| Operating Margin | 5.00% | 3.85% | +1.15 | GRDN | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 3.04% | +0.36 | GRDN | /net-margins <GO> |
| Revenue Growth (YoY) | 17.90% | 10.14% | +7.76 | GRDN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.58% | -0.58 | COST | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.39 | 9.38 | +3.01 | GRDN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | GRDN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 4.46% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.6 | 57.7 | -7.13 | COST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.73 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 43.8x | 39.7x | +4.08 | COST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.56B | $441.39B | -$438.83B | COST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRDN REV | COST REV | GRDN GROSS % | COST GROSS % | GRDN FCF | COST FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $303.15B | — | 12.8% | — | $9.38B |
| FY 2025 | $1.45B | $275.24B | 20.2% | 12.8% | $100.3M | $7.84B |
| FY 2024 | $1.23B | $254.45B | 19.9% | 12.6% | $58.0M | $6.63B |
| FY 2023 | — | $242.29B | — | 12.3% | — | $6.75B |
| FY 2022 | — | $226.95B | — | 12.2% | — | $3.50B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDN // BETA —
COST // BETA 0.73